Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations (Unaudited)

v3.23.3
Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Total revenue $ 1,557 $ 10,675 $ 137,388 $ 186,661
Total cost of revenue 2,787 10,675 114,188 186,661
Gross profit (1,230) 0 23,200 0
Operating expenses:        
Research and development 1,690,538 780,151 4,337,254 2,337,081
General and administrative 854,025 768,957 2,682,951 2,356,543
Sales and marketing 293,963 207,443 870,189 660,024
Total operating expenses 2,838,526 1,756,551 7,890,394 5,353,648
Loss from operations (2,839,756) (1,756,551) (7,867,194) (5,353,648)
Interest income, net 99,275 52,781 318,922 55,243
Net loss $ (2,740,481) $ (1,703,770) $ (7,548,272) $ (5,298,405)
Net loss per share – basic and diluted (in dollars per share) $ (0.44) $ (0.28) $ (1.22) $ (0.86)
Weighted average number of shares outstanding – basic and diluted (in shares) 6,192,286 6,157,625 6,185,447 6,156,876
Development Revenue [Member]        
Total revenue $ 1,557 $ 0 $ 100,000 $ 0
Total cost of revenue 2,787 0 76,800 0
Grant [Member]        
Total revenue 0 10,675 37,388 186,661
Total cost of revenue $ 0 $ 10,675 $ 37,388 $ 186,661